Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3065

Actual shortage: 231 (8%)
Anticipated shortage: 16 (1%)
Avoided shortage: 9 (0%)
Resolved: 2809 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ANAFRANIL 25MG TABLET Resolved 2024-03-15 2024-03-22 222473
APO-SERTRALINE 25MG CAPSULE Resolved 2024-03-15 2024-05-03 222481
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2024-04-12 2024-05-31 224977
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2024-05-10 2024-05-31 227717
APO-HYDRALAZINE 25MG TABLET TABLET Actual shortage 2024-05-24 2024-05-24 228804
APO-ATOMOXETINE 25MG CAPSULE Anticipated shortage 2024-05-30 2024-05-30 229164
APO-NAPRO-NA 275MG TABLET Resolved 2018-05-15 2018-10-05 49499
APO-NAPRO-NA 275MG TABLET Resolved 2022-06-06 2022-08-22 162077
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-25 2017-11-03 16938
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-05-24 37963
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-04 2018-08-01 54285
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-18 2019-07-17 69918
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-05 2021-02-16 133382
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-16 2021-09-27 137581
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-14 159719
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2023-04-27 185927
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-10 208400
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-12 212371

Showing 1661 to 1680 of 3065

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-DILTIAZ CD 300MG CAPSULE (CONTROLLED-DELIVERY) Discontinued 2019-02-01 2019-02-02 74366
APO-OXAZEPAM 30MG TABLET Discontinued 2018-09-08 2019-06-12 60681
APO-TEMAZEPAM 30MG CAPSULE Discontinued 2018-10-23 2019-01-07 65482
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971
APO-ACETAMINOPHEN 325MG TABLET Discontinued 2018-10-11 2018-10-11 63845
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2018-10-25 2018-10-25 65585
ACETAMINOPHEN TABLETS USP 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71219
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71222
APO-CANDESARTAN 32MG TABLET Discontinued 2018-09-07 2018-09-15 60328
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965
APO-DILTIAZ TZ 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1078
APO-BROMAZEPAM 3MG TABLET Discontinued 2018-09-07 2019-06-12 60307
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROMORPHONE CR 4.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110974
APO-ACEBUTOLOL 400MG TABLET Discontinued 2017-03-31 2018-02-05 4965
APO-IBUPROFEN 400MG TABLET Discontinued 2018-09-07 2018-09-15 60530
APO-IBUPROFEN 400MG TABLET Discontinued 2019-01-02 2019-01-02 70799
IBUPROFEN CAPLETS 400MG TABLET Discontinued 2019-01-07 2019-07-13 71451

Showing 241 to 260 of 356